XML 10 R2.htm IDEA: XBRL DOCUMENT v3.24.1
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) - GBP (£)
£ in Thousands
 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
 [1]
Disclosure of attribution of expenses by nature to their function [line items]    
REVENUE £ 371,973 £ 401,410
Cost of sales (272,630) (261,496)
GROSS PROFIT 99,343 139,914
Selling, general and administrative expenses (78,618) (79,886)
OPERATING PROFIT 20,725 60,028
Net finance income / (expense) 7,193 (1,189)
PROFIT BEFORE TAX 27,918 58,839
Tax on profit on ordinary activities (7,205) (12,092)
PROFIT FOR THE YEAR AND PROFIT ATTRIBUTABLE TO THE EQUITY HOLDERS OF THE COMPANY 20,713 46,747
Items that may be reclassified subsequently to profit or loss:    
Exchange differences on translating foreign operations 1,869 823
Total comprehensive income for the year £ 22,582 £ 47,570
EARNINGS PER SHARE (EPS):    
Weighted average number of shares outstanding - Basic (in shares) 58,101,072 56,962,777
Weighted average number of shares outstanding - Diluted (in shares) 58,367,296 57,923,559
Basic EPS (in gbp per share) £ 0.36 £ 0.82
Diluted EPS (in gbp per share) £ 0.35 £ 0.81
Direct cost of sales    
Disclosure of attribution of expenses by nature to their function [line items]    
Cost of sales £ (259,412) £ (249,253)
Allocated cost of sales    
Disclosure of attribution of expenses by nature to their function [line items]    
Cost of sales £ (13,218) £ (12,243)
[1]
(1)The presentation of the income statement has been changed to no longer separately disclose the net impairment gains/losses on financial assets on the face of the Condensed Consolidated Statements of Comprehensive Income, but include them within Selling, general and administrative expenses.